Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
39.58
+2.29 (6.14%)
At close: May 12, 2025, 4:00 PM
40.50
+0.92 (2.32%)
After-hours: May 12, 2025, 4:28 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.26 billion as of May 12, 2025. Its market cap has decreased by -13.60% in one year.
Market Cap
2.26B
Enterprise Value
1.59B
1-Year Change
-13.60%
Ranking
Category
Stock Price
$39.58
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.26B, an increase of 179.91%. That is a compound annual growth rate of 75.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.13B | -17.25% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |